Review





Similar Products

97
Cell Signaling Technology Inc anti n cadherin
Anti N Cadherin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/N-Cadherin+Antibody/10__1038_slash_s41698___026___01791___6-298-30-33
Average 97 stars, based on 1 article reviews
anti n cadherin - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
Aviva Systems piezo2
Piezo2, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/FAM38B+Antibody+-+N-terminal+region+(OAAB11723)/pm42981814-54-12-13
Average 94 stars, based on 1 article reviews
piezo2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech n cadherin
Overexpression of KLK11 suppresses the aggressive properties of MDA-MB-231 cells. ( A ) Western blot analysis confirming KLK11 overexpression in MDA-MB-231 cells. ( B ) Quantification of KLK11 protein expression following overexpression. ( C ) KLK11 mRNA expression in overexpressing cells. ( D ) CCK-8 assay assessing cell viability after KLK11 overexpression. ( E ) Colony formation assay evaluating the clonogenic capacity of MDA-MB-231 cells after KLK11 overexpression. ( F ) Quantification of colony numbers. ( G ) Wound healing assay examining the motility of KLK11-overexpressing cells. (Scale bar = 100 μm). ( H ) Quantification of wound closure rates. ( I ) Transwell invasion assay evaluating the invasive behavior of KLK11-overexpressing MDA-MB-231 cells. (Scale bar = 100 μm). ( J ) Quantification of invaded cells. ( K ) EMT markers <t>(E-cadherin,</t> N-cadherin, Vimentin, and Snail) levels in KLK11-overexpressing cells. ( L – O ) Quantification of the respective protein expression levels. Data are presented as mean ± SD, n = 3. Statistical significance between the two groups was determined using an unpaired Student’s t -test. Statistical significance is indicated as ** p < 0.01 and *** p < 0.001.
N Cadherin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/N-cadherin+Polyclonal+antibody/pmc13772754-61-49-52
Average 96 stars, based on 1 article reviews
n cadherin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
ABclonal Biotechnology rabbit monoclonal anti tbk1
Overexpression of KLK11 suppresses the aggressive properties of MDA-MB-231 cells. ( A ) Western blot analysis confirming KLK11 overexpression in MDA-MB-231 cells. ( B ) Quantification of KLK11 protein expression following overexpression. ( C ) KLK11 mRNA expression in overexpressing cells. ( D ) CCK-8 assay assessing cell viability after KLK11 overexpression. ( E ) Colony formation assay evaluating the clonogenic capacity of MDA-MB-231 cells after KLK11 overexpression. ( F ) Quantification of colony numbers. ( G ) Wound healing assay examining the motility of KLK11-overexpressing cells. (Scale bar = 100 μm). ( H ) Quantification of wound closure rates. ( I ) Transwell invasion assay evaluating the invasive behavior of KLK11-overexpressing MDA-MB-231 cells. (Scale bar = 100 μm). ( J ) Quantification of invaded cells. ( K ) EMT markers <t>(E-cadherin,</t> N-cadherin, Vimentin, and Snail) levels in KLK11-overexpressing cells. ( L – O ) Quantification of the respective protein expression levels. Data are presented as mean ± SD, n = 3. Statistical significance between the two groups was determined using an unpaired Student’s t -test. Statistical significance is indicated as ** p < 0.01 and *** p < 0.001.
Rabbit Monoclonal Anti Tbk1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/NAK%2FTBK1+(N-term)+Rabbit+mAb/pm42976855-322-228-231
Average 95 stars, based on 1 article reviews
rabbit monoclonal anti tbk1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc rabbit anti myc
Overexpression of KLK11 suppresses the aggressive properties of MDA-MB-231 cells. ( A ) Western blot analysis confirming KLK11 overexpression in MDA-MB-231 cells. ( B ) Quantification of KLK11 protein expression following overexpression. ( C ) KLK11 mRNA expression in overexpressing cells. ( D ) CCK-8 assay assessing cell viability after KLK11 overexpression. ( E ) Colony formation assay evaluating the clonogenic capacity of MDA-MB-231 cells after KLK11 overexpression. ( F ) Quantification of colony numbers. ( G ) Wound healing assay examining the motility of KLK11-overexpressing cells. (Scale bar = 100 μm). ( H ) Quantification of wound closure rates. ( I ) Transwell invasion assay evaluating the invasive behavior of KLK11-overexpressing MDA-MB-231 cells. (Scale bar = 100 μm). ( J ) Quantification of invaded cells. ( K ) EMT markers <t>(E-cadherin,</t> N-cadherin, Vimentin, and Snail) levels in KLK11-overexpressing cells. ( L – O ) Quantification of the respective protein expression levels. Data are presented as mean ± SD, n = 3. Statistical significance between the two groups was determined using an unpaired Student’s t -test. Statistical significance is indicated as ** p < 0.01 and *** p < 0.001.
Rabbit Anti Myc, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/c-Myc%2FN-Myc+Rabbit+mAb/pmc13773482-398-20-22
Average 96 stars, based on 1 article reviews
rabbit anti myc - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech anti mmp9
Transcriptomic characterization and experimental validation of CDNV‐mediated NF‐κB pathway inhibition. (A) RNA‐seq heatmap of 15 hallmark genes across Control, H 2 O 2 , and H 2 O 2 + CDNVs groups (n = 3 biological replicates per group). (B, C) Volcano plots of differentially expressed genes (DEGs) in (B) H 2 O 2 versus Control and (C) H 2 O 2 + CDNVs versus H 2 O 2 . (D) GO biological process enrichment analysis of identified DEGs. (E) KEGG pathway enrichment analysis of identified DEGs. (F–I) Gene set enrichment analysis (GSEA) of (F) TNF signaling pathway, (G) NF‐κB signaling pathway, (H) cellular senescence, and (I) collagen‐containing ECM in the H 2 O 2 + CDNVs versus H 2 O 2 comparison. (J) Western blot analysis of p‐IκB‐α, IκB‐α, p‐p65, p65, and GAPDH across indicated treatment groups. (K) Densitometric quantification of total IκB‐α, p‐IκB‐α/IκB‐α, and p‐p65/p65 ratios (n = 3). Data are presented as mean ± SD; *** p < 0.001 by one‐way ANOVA followed by Tukey's post‐hoc test. (L) IF staining of p65 (green) counterstained with DAPI (blue). Scale bar = 50 µm.
Anti Mmp9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/MMP9+(N-terminal)+Polyclonal+antibody/pmc13749007-300-27-29
Average 96 stars, based on 1 article reviews
anti mmp9 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

92
OriGene hamster anti mouse mfg e8
Transcriptomic characterization and experimental validation of CDNV‐mediated NF‐κB pathway inhibition. (A) RNA‐seq heatmap of 15 hallmark genes across Control, H 2 O 2 , and H 2 O 2 + CDNVs groups (n = 3 biological replicates per group). (B, C) Volcano plots of differentially expressed genes (DEGs) in (B) H 2 O 2 versus Control and (C) H 2 O 2 + CDNVs versus H 2 O 2 . (D) GO biological process enrichment analysis of identified DEGs. (E) KEGG pathway enrichment analysis of identified DEGs. (F–I) Gene set enrichment analysis (GSEA) of (F) TNF signaling pathway, (G) NF‐κB signaling pathway, (H) cellular senescence, and (I) collagen‐containing ECM in the H 2 O 2 + CDNVs versus H 2 O 2 comparison. (J) Western blot analysis of p‐IκB‐α, IκB‐α, p‐p65, p65, and GAPDH across indicated treatment groups. (K) Densitometric quantification of total IκB‐α, p‐IκB‐α/IκB‐α, and p‐p65/p65 ratios (n = 3). Data are presented as mean ± SD; *** p < 0.001 by one‐way ANOVA followed by Tukey's post‐hoc test. (L) IF staining of p65 (green) counterstained with DAPI (blue). Scale bar = 50 µm.
Hamster Anti Mouse Mfg E8, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/MFGE8+Hamster+Monoclonal+Antibody/pm43003089-578-20-23
Average 92 stars, based on 1 article reviews
hamster anti mouse mfg e8 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

96
Proteintech anti n cadherin
Transcriptomic characterization and experimental validation of CDNV‐mediated NF‐κB pathway inhibition. (A) RNA‐seq heatmap of 15 hallmark genes across Control, H 2 O 2 , and H 2 O 2 + CDNVs groups (n = 3 biological replicates per group). (B, C) Volcano plots of differentially expressed genes (DEGs) in (B) H 2 O 2 versus Control and (C) H 2 O 2 + CDNVs versus H 2 O 2 . (D) GO biological process enrichment analysis of identified DEGs. (E) KEGG pathway enrichment analysis of identified DEGs. (F–I) Gene set enrichment analysis (GSEA) of (F) TNF signaling pathway, (G) NF‐κB signaling pathway, (H) cellular senescence, and (I) collagen‐containing ECM in the H 2 O 2 + CDNVs versus H 2 O 2 comparison. (J) Western blot analysis of p‐IκB‐α, IκB‐α, p‐p65, p65, and GAPDH across indicated treatment groups. (K) Densitometric quantification of total IκB‐α, p‐IκB‐α/IκB‐α, and p‐p65/p65 ratios (n = 3). Data are presented as mean ± SD; *** p < 0.001 by one‐way ANOVA followed by Tukey's post‐hoc test. (L) IF staining of p65 (green) counterstained with DAPI (blue). Scale bar = 50 µm.
Anti N Cadherin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/N-cadherin+Polyclonal+antibody/pm43000378-33-6-23
Average 96 stars, based on 1 article reviews
anti n cadherin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti n cadherin
Transcriptomic characterization and experimental validation of CDNV‐mediated NF‐κB pathway inhibition. (A) RNA‐seq heatmap of 15 hallmark genes across Control, H 2 O 2 , and H 2 O 2 + CDNVs groups (n = 3 biological replicates per group). (B, C) Volcano plots of differentially expressed genes (DEGs) in (B) H 2 O 2 versus Control and (C) H 2 O 2 + CDNVs versus H 2 O 2 . (D) GO biological process enrichment analysis of identified DEGs. (E) KEGG pathway enrichment analysis of identified DEGs. (F–I) Gene set enrichment analysis (GSEA) of (F) TNF signaling pathway, (G) NF‐κB signaling pathway, (H) cellular senescence, and (I) collagen‐containing ECM in the H 2 O 2 + CDNVs versus H 2 O 2 comparison. (J) Western blot analysis of p‐IκB‐α, IκB‐α, p‐p65, p65, and GAPDH across indicated treatment groups. (K) Densitometric quantification of total IκB‐α, p‐IκB‐α/IκB‐α, and p‐p65/p65 ratios (n = 3). Data are presented as mean ± SD; *** p < 0.001 by one‐way ANOVA followed by Tukey's post‐hoc test. (L) IF staining of p65 (green) counterstained with DAPI (blue). Scale bar = 50 µm.
Anti N Cadherin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/N-cadherin+Antibody/pmc13744505-53-46-50
Average 96 stars, based on 1 article reviews
anti n cadherin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech anti n cadherin antibody
Transcriptomic characterization and experimental validation of CDNV‐mediated NF‐κB pathway inhibition. (A) RNA‐seq heatmap of 15 hallmark genes across Control, H 2 O 2 , and H 2 O 2 + CDNVs groups (n = 3 biological replicates per group). (B, C) Volcano plots of differentially expressed genes (DEGs) in (B) H 2 O 2 versus Control and (C) H 2 O 2 + CDNVs versus H 2 O 2 . (D) GO biological process enrichment analysis of identified DEGs. (E) KEGG pathway enrichment analysis of identified DEGs. (F–I) Gene set enrichment analysis (GSEA) of (F) TNF signaling pathway, (G) NF‐κB signaling pathway, (H) cellular senescence, and (I) collagen‐containing ECM in the H 2 O 2 + CDNVs versus H 2 O 2 comparison. (J) Western blot analysis of p‐IκB‐α, IκB‐α, p‐p65, p65, and GAPDH across indicated treatment groups. (K) Densitometric quantification of total IκB‐α, p‐IκB‐α/IκB‐α, and p‐p65/p65 ratios (n = 3). Data are presented as mean ± SD; *** p < 0.001 by one‐way ANOVA followed by Tukey's post‐hoc test. (L) IF staining of p65 (green) counterstained with DAPI (blue). Scale bar = 50 µm.
Anti N Cadherin Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+n/N-cadherin+Polyclonal+antibody/pm42993326-190-21-24
Average 96 stars, based on 1 article reviews
anti n cadherin antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


Overexpression of KLK11 suppresses the aggressive properties of MDA-MB-231 cells. ( A ) Western blot analysis confirming KLK11 overexpression in MDA-MB-231 cells. ( B ) Quantification of KLK11 protein expression following overexpression. ( C ) KLK11 mRNA expression in overexpressing cells. ( D ) CCK-8 assay assessing cell viability after KLK11 overexpression. ( E ) Colony formation assay evaluating the clonogenic capacity of MDA-MB-231 cells after KLK11 overexpression. ( F ) Quantification of colony numbers. ( G ) Wound healing assay examining the motility of KLK11-overexpressing cells. (Scale bar = 100 μm). ( H ) Quantification of wound closure rates. ( I ) Transwell invasion assay evaluating the invasive behavior of KLK11-overexpressing MDA-MB-231 cells. (Scale bar = 100 μm). ( J ) Quantification of invaded cells. ( K ) EMT markers (E-cadherin, N-cadherin, Vimentin, and Snail) levels in KLK11-overexpressing cells. ( L – O ) Quantification of the respective protein expression levels. Data are presented as mean ± SD, n = 3. Statistical significance between the two groups was determined using an unpaired Student’s t -test. Statistical significance is indicated as ** p < 0.01 and *** p < 0.001.

Journal: Breast Cancer : Targets and Therapy

Article Title: KLK11 Overexpression Inhibits YAP-Associated Signaling and Suppresses Malignant Phenotypes in Triple-Negative Breast Cancer Cells

doi: 10.2147/BCTT.S649820

Figure Lengend Snippet: Overexpression of KLK11 suppresses the aggressive properties of MDA-MB-231 cells. ( A ) Western blot analysis confirming KLK11 overexpression in MDA-MB-231 cells. ( B ) Quantification of KLK11 protein expression following overexpression. ( C ) KLK11 mRNA expression in overexpressing cells. ( D ) CCK-8 assay assessing cell viability after KLK11 overexpression. ( E ) Colony formation assay evaluating the clonogenic capacity of MDA-MB-231 cells after KLK11 overexpression. ( F ) Quantification of colony numbers. ( G ) Wound healing assay examining the motility of KLK11-overexpressing cells. (Scale bar = 100 μm). ( H ) Quantification of wound closure rates. ( I ) Transwell invasion assay evaluating the invasive behavior of KLK11-overexpressing MDA-MB-231 cells. (Scale bar = 100 μm). ( J ) Quantification of invaded cells. ( K ) EMT markers (E-cadherin, N-cadherin, Vimentin, and Snail) levels in KLK11-overexpressing cells. ( L – O ) Quantification of the respective protein expression levels. Data are presented as mean ± SD, n = 3. Statistical significance between the two groups was determined using an unpaired Student’s t -test. Statistical significance is indicated as ** p < 0.01 and *** p < 0.001.

Article Snippet: Following blocking with 5% non-fat milk, the membranes were incubated overnight at 4 °C with specific primary antibodies, including KLK11 (1:5000; 67427-1-Ig, Proteintech, China), YAP (1:2000; 13584-1-AP, Proteintech, China), p-YAP (1:2000; 29018-1-AP, Proteintech, China), LATS1 (1:500; 17049-1-AP, Proteintech, China), TAZ (1:1000; 23306-1-AP, Proteintech, China), E-cadherin (1:20000; 20874-1-AP, Proteintech, China), N-cadherin (1:2000; 22018-1-AP, Proteintech, China), Vimentin (1:20000; 10366-1-AP, Proteintech, China), Snail (1:500; 13099-1-AP, Proteintech, China), and GAPDH (1:50000; 60004-1-Ig, Proteintech, China).

Techniques: Over Expression, Western Blot, Analysis, Expressing, CCK-8 Assay, Colony Assay, Wound Healing Assay, Transwell Invasion Assay

Transcriptomic characterization and experimental validation of CDNV‐mediated NF‐κB pathway inhibition. (A) RNA‐seq heatmap of 15 hallmark genes across Control, H 2 O 2 , and H 2 O 2 + CDNVs groups (n = 3 biological replicates per group). (B, C) Volcano plots of differentially expressed genes (DEGs) in (B) H 2 O 2 versus Control and (C) H 2 O 2 + CDNVs versus H 2 O 2 . (D) GO biological process enrichment analysis of identified DEGs. (E) KEGG pathway enrichment analysis of identified DEGs. (F–I) Gene set enrichment analysis (GSEA) of (F) TNF signaling pathway, (G) NF‐κB signaling pathway, (H) cellular senescence, and (I) collagen‐containing ECM in the H 2 O 2 + CDNVs versus H 2 O 2 comparison. (J) Western blot analysis of p‐IκB‐α, IκB‐α, p‐p65, p65, and GAPDH across indicated treatment groups. (K) Densitometric quantification of total IκB‐α, p‐IκB‐α/IκB‐α, and p‐p65/p65 ratios (n = 3). Data are presented as mean ± SD; *** p < 0.001 by one‐way ANOVA followed by Tukey's post‐hoc test. (L) IF staining of p65 (green) counterstained with DAPI (blue). Scale bar = 50 µm.

Journal: Advanced Science

Article Title: Microenvironment‐Responsive Biomimetic Hydrogels Delivering Cistanche Deserticola‐Derived Nanovesicles for Intervertebral Disc Degeneration

doi: 10.1002/advs.78698

Figure Lengend Snippet: Transcriptomic characterization and experimental validation of CDNV‐mediated NF‐κB pathway inhibition. (A) RNA‐seq heatmap of 15 hallmark genes across Control, H 2 O 2 , and H 2 O 2 + CDNVs groups (n = 3 biological replicates per group). (B, C) Volcano plots of differentially expressed genes (DEGs) in (B) H 2 O 2 versus Control and (C) H 2 O 2 + CDNVs versus H 2 O 2 . (D) GO biological process enrichment analysis of identified DEGs. (E) KEGG pathway enrichment analysis of identified DEGs. (F–I) Gene set enrichment analysis (GSEA) of (F) TNF signaling pathway, (G) NF‐κB signaling pathway, (H) cellular senescence, and (I) collagen‐containing ECM in the H 2 O 2 + CDNVs versus H 2 O 2 comparison. (J) Western blot analysis of p‐IκB‐α, IκB‐α, p‐p65, p65, and GAPDH across indicated treatment groups. (K) Densitometric quantification of total IκB‐α, p‐IκB‐α/IκB‐α, and p‐p65/p65 ratios (n = 3). Data are presented as mean ± SD; *** p < 0.001 by one‐way ANOVA followed by Tukey's post‐hoc test. (L) IF staining of p65 (green) counterstained with DAPI (blue). Scale bar = 50 µm.

Article Snippet: The cells were then incubated overnight at 4°C with primary antibodies diluted in 1% BSA, including anti‐COL II (28459‐1‐AP, Proteintech, China), anti‐ACAN (68350‐1‐Ig, Proteintech), anti‐MMP13 (83188–2‐RR, Proteintech), anti‐MMP9 (10375–2‐AP, Proteintech), anti‐p16 (ab270058, Abcam, UK), anti‐p21 (ab109520, Abcam), anti‐IL‐1β (26048–1‐AP, Proteintech), and anti‐IL‐6 (21865‐1‐AP, Proteintech).

Techniques: Biomarker Discovery, Inhibition, RNA Sequencing, Control, Analysis, Gene Set Enrichment Analysis, Comparison, Western Blot, Staining